Article ID Journal Published Year Pages File Type
2981462 The Journal of Thoracic and Cardiovascular Surgery 2012 7 Pages PDF
Abstract

ObjectiveInvasive lung tumors are associated with intercellular adhesion molecule-1 (ICAM-1) expression. Secretory phospholipase A2 (sPLA2) enzymes produce inflammatory mediators that stimulate ICAM-1 expression, and upregulation of PLA2 activity can enhance metastasis. We hypothesize a link between sPLA2 activity, ICAM-1 expression, and tumor cell invasion. We propose that inhibition of sPLA2 modulates ICAM-1 expression in cancer cells and attenuates their invasiveness.MethodsHuman lung adenocarcinoma cells (A549) were treated with an ICAM-1 blocking antibody and assayed for invasion. Lung cancer cells (A549 and H358) were then treated with an sPLA2 inhibitor and evaluated by immunoblotting for ICAM-1 expression. Next cells (A549) treated with sPLA2 inhibitor were assayed for invasion. Finally, sPLA2 messenger RNA and protein expression were evaluated by quantitative reverse-transcriptase polymerase chain reaction and immunofluorescence microscopy, respectively. Statistical analysis was performed by the Student t test or analysis of variance, as appropriate.ResultsAntibody blockade of ICAM-1 decreased lung cancer cell invasion. sPLA2 inhibition significantly reduced ICAM-1 expression and invasion. sPLA2 inhibition also significantly decreased sPLA2 mRNA expression and immunofluorescent staining of sPLA2.ConclusionssPLA2 plays a significant role in mediating the inflammatory signals that induce ICAM-1 expression in lung cancer cells. Inhibition of the enzyme can significantly decrease ICAM-1 expression and subsequent cancer cell invasion. This lays the groundwork for further investigation into the cellular mechanisms of sPLA2 and its role in lung cancer.

Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , ,